CD206 MODULATORS THEIR USE AND METHODS FOR PREPARATION Read more about CD206 MODULATORS THEIR USE AND METHODS FOR PREPARATION China202080096478.2Filed on 2022-08-30
CD206 MODULATORS THEIR USE AND METHODS FOR PREPARATION Read more about CD206 MODULATORS THEIR USE AND METHODS FOR PREPARATION Canada3165339Filed on 2020-12-16
COMPOSITIONS AND METHODS FOR DETERMINING RESPONSIVENESS TO IMMUNE CHECKPOINT INHIBITORS (ICI), INCREASING EFFECTIVENESS OF ICI, AND TREATING CANCER Read more about COMPOSITIONS AND METHODS FOR DETERMINING RESPONSIVENESS TO IMMUNE CHECKPOINT INHIBITORS (ICI), INCREASING EFFECTIVENESS OF ICI, AND TREATING CANCER Patent Cooperation TreatyPCT/US2022/032917Filed on 2022-06-09
Anti-B-cell Maturation Antigen Chimeric Antigen Receptors With Human Domains Read more about Anti-B-cell Maturation Antigen Chimeric Antigen Receptors With Human Domains Spain18759189.6Filed on 2018-06-28
Anti-B-cell Maturation Antigen Chimeric Antigen Receptors With Human Domains Read more about Anti-B-cell Maturation Antigen Chimeric Antigen Receptors With Human Domains Germany18759189.6Filed on 2018-06-28
Anti-B-cell Maturation Antigen Chimeric Antigen Receptors With Human Domains Read more about Anti-B-cell Maturation Antigen Chimeric Antigen Receptors With Human Domains Italy18759189.6Filed on 2018-06-28
Anti-B-cell Maturation Antigen Chimeric Antigen Receptors With Human Domains Read more about Anti-B-cell Maturation Antigen Chimeric Antigen Receptors With Human Domains United Kingdom18759189.6Filed on 2018-06-28
Anti-B-cell Maturation Antigen Chimeric Antigen Receptors With Human Domains Read more about Anti-B-cell Maturation Antigen Chimeric Antigen Receptors With Human Domains France18759189.6Filed on 2018-06-28
PERSONALIZED TUMOR VACCINE AND USE THEREOF FOR CANCER IMMUNOTHERAPY Read more about PERSONALIZED TUMOR VACCINE AND USE THEREOF FOR CANCER IMMUNOTHERAPY US Application 17/783,866Filed on 2022-06-09
PERSONALIZED TUMOR VACCINE AND USE THEREOF FOR CANCER IMMUNOTHERAPY Read more about PERSONALIZED TUMOR VACCINE AND USE THEREOF FOR CANCER IMMUNOTHERAPY China202080086575.3Filed on 2020-12-11